CTMX Historical Earnings image   This CTMX historical earnings page last updated 11/11/2024
CTMX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202411/7/20240.03B
Q2 20248/8/20240.03B
Q1 20245/8/20240.04B
Q4 20233/11/20240.03B
Q3 202311/7/20230.03B
Q2 20238/8/20230.02B
Q1 20235/9/20230.02B
Q4 20223/27/20230.00B
Q3 202211/8/20220.02B
Q2 20228/4/20220.02B
Q1 20225/5/20220.02B
Q4 20213/1/20220.02B
Q3 202111/4/20210.02B
Q2 20218/5/20210.02B
Q1 20215/6/20210.02B
Q4 20202/24/20210.02B
Q3 202011/5/20200.02B
Q2 20208/6/20200.02B
Q1 20205/7/20200.05B
Q4 20192/27/20200.01B
Q3 201911/7/20190.01B
Q2 20198/7/20190.01B
Q1 20195/9/20190.03B
Q4 20182/27/201911.47M
Q3 201811/6/201812.51M
Q2 20188/8/201821.34M
Q1 20185/9/201814.18M
Q4 20173/7/201827.07M
Q3 201711/7/201724.14M
Q2 20178/7/20178.75M
Q1 20175/5/201711.65M
Q4 20163/2/20176.27M
Q3 201611/3/20163.45M
Q2 20168/3/20163.09M
Q1 20165/6/20162.22M
Q4 20153/7/20161.99M
Q3 201511/23/20151.94M
CTMX Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202411/7/20240.070
Q2 20248/8/2024-0.080
Q1 20245/8/20240.170
Q4 20233/11/20240.010
Q3 202311/7/20230.040
Q2 20238/8/2023-0.020
Q1 20235/9/2023-0.050
Q4 20223/27/2023-0.420
Q3 202211/8/2022-0.350
Q2 20228/4/2022-0.370
Q1 20225/5/2022-0.370
Q4 20213/1/2022-0.400
Q3 202111/4/2021-0.350
Q2 20218/5/2021-0.300
Q1 20215/6/2021-0.260
Q4 20202/24/2021-0.310
Q3 202011/5/2020-0.320
Q2 20208/6/2020-0.340
Q1 20205/7/20200.260
Q4 20192/27/2020-0.790
Q3 201911/7/2019-0.520
Q2 20198/7/2019-0.640
Q1 20195/9/2019-0.310
Q4 20182/27/2019-0.74
Q3 201811/6/2018-0.53
Q2 20188/8/2018-0.35
Q1 20185/9/2018-0.4
Q4 20173/7/20180.03
Q3 201711/7/2017-0.28
Q2 20178/7/2017-0.69
Q1 20175/5/2017-0.23
Q4 20163/2/2017-0.39
Q3 201611/3/2016-0.4
Q2 20168/3/2016-0.39
Q1 20165/6/2016-0.44
Q4 20153/7/2016-0.39
Q3 201511/23/2015-14.26
Quotes delayed 20 minutes

Email EnvelopeFree CTMX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
CytomX Therapeutics (CTMX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CTNM Historical Earnings
CTSO Historical Earnings
CTXR Historical Earnings
CUE Historical Earnings
CUTR Historical Earnings
CVRX Historical Earnings
CVS Historical Earnings
CWBR Historical Earnings
CYCC Historical Earnings
CYCN Historical Earnings
What was the record high CTMX historical earnings result?
In terms of earnings or revenue, what is the best CTMX historical earnings result that CytomX Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CTMX historical earnings result was set in Q1 2020, when CytomX Therapeutics posted results of 0.260/share. The most successful revenue quarter within our data set was Q1 2020 when CytomX Therapeutics reported revenue of 0.05B.

What was the lowest CytomX Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CTMX has reported, and when?

✔️Accepted answer: Within our data set, the lowest CTMX historical earnings result was set in Q3 2015, when CytomX Therapeutics posted results of -14.26/share. The smallest revenue quarter within our data set was Q4 2022 when CytomX Therapeutics reported revenue of 0.00B.

On this page we presented the CTMX historical earnings date information for CytomX Therapeutics. Reviewing that CTMX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2020, when CTMX posted gaap of 0.260/share. Meanwhile the lowest CTMX historical earnings result was in Q3 2015, when CTMX posted gaap of -14.26/share. Moving to CytomX Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2020 when CTMX reported 0.05B in revenue, while the smallest revenue quarter was Q4 2022 when CTMX reported 0.00B in revenue.

For self directed investors doing their due diligence on CTMX or any other given stock, their research can benefit from looking into all of the CytomX Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into CytomX Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CTMX. Thanks for visiting, and the next time you need to research CTMX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Funds Holding PFPT, ETFs Holding TYC, YUMC Historical Stock Prices.

 

CTMX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.